# Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer

> **NCT00040638** · PHASE2 · COMPLETED · sponsor: **Telik** · enrollment: 40 (—)

## Conditions studied

- Carcinoma, Non-small-cell Lung

## Interventions

- **DRUG:** TLK286

## Key facts

- **NCT ID:** NCT00040638
- **Lead sponsor:** Telik
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** 2003-08
- **Final completion:** 2003-08
- **Target enrollment:** 40 (—)
- **Last updated:** 2011-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00040638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00040638, "Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00040638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*